We innovate to advance science in dermatology and deliver treatments to people with skin diseases. LEO Pharma’s global R&D organization is powered by more than 700 scientists and specialists who all possess in-depth knowledge of the skin.
Products in our pipeline are investigational only. Safety and efficacy have not been established.
LEO Pharma Pipeline Overview (Q2 2020)
Click to expand Pipeline Overview.
Find more information at www.clinicaltrials.gov.